SYRE logo

Spyre Therapeutics (SYRE) Total Assets

Annual Total Assets

$341.86 M
+$270.71 M+380.52%

December 31, 2023


Summary


Performance

SYRE Total Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSYREbalance sheetmetrics:

Quarterly Total Assets

$421.09 M
-$14.98 M-3.43%

September 30, 2024


Summary


Performance

SYRE Quarterly Total Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSYREbalance sheetmetrics:

Total Assets Formula

Total Assets = Current Assets + Non-Current Assets

SYRE Total Assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+380.5%0.0%
3 y3 years+111.5%+359.9%
5 y5 years+339.8%+359.9%

SYRE Total Assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+380.5%-13.6%+702.8%
5 y5-yearat high+380.5%-13.6%+702.8%
alltimeall timeat high>+9999.0%-13.6%>+9999.0%

Spyre Therapeutics Total Assets History

DateAnnualQuarterly
Sep 2024
-
$421.09 M(-3.4%)
Jun 2024
-
$436.07 M(-10.6%)
Mar 2024
-
$487.60 M(+42.6%)
Dec 2023
$341.86 M(+380.5%)
$341.86 M(+64.9%)
Sep 2023
-
$207.26 M(-14.9%)
Jun 2023
-
$243.53 M(+364.3%)
Mar 2023
-
$52.45 M(-26.3%)
Dec 2022
$71.14 M(-35.3%)
-
Dec 2022
-
$71.14 M(-22.3%)
Sep 2022
-
$91.57 M(-14.2%)
Jun 2022
-
$106.71 M(+28.3%)
Mar 2022
-
$83.17 M(-24.3%)
Dec 2021
$109.93 M(-32.0%)
$109.93 M(-14.8%)
Sep 2021
-
$129.06 M(-12.2%)
Jun 2021
-
$146.98 M(-10.2%)
Mar 2021
-
$163.61 M(+1.2%)
Dec 2020
$161.62 M(+94.3%)
$161.62 M(+3.8%)
Sep 2020
-
$155.63 M(-10.0%)
Jun 2020
-
$172.91 M(+166.9%)
Mar 2020
-
$64.78 M(-22.1%)
Dec 2019
$83.18 M
$83.18 M(-16.9%)
DateAnnualQuarterly
Sep 2019
-
$100.10 M(-14.8%)
Jun 2019
-
$117.49 M(-8.6%)
Mar 2019
-
$128.52 M(+65.3%)
Dec 2018
$77.74 M(+38.6%)
$77.74 M(+9.1%)
Sep 2018
-
$71.28 M(-10.6%)
Jun 2018
-
$79.71 M(+60.1%)
Mar 2018
-
$49.79 M(-11.2%)
Dec 2017
$56.08 M(-16.4%)
$56.08 M(-7.3%)
Sep 2017
-
$60.50 M(-9.9%)
Jun 2017
-
$67.14 M(+9.6%)
Mar 2017
-
$61.27 M(-8.6%)
Dec 2016
$67.06 M(+73.5%)
$67.06 M(-6.9%)
Sep 2016
-
$72.06 M(-6.8%)
Jun 2016
-
$77.30 M(+117.5%)
Mar 2016
-
$35.54 M(-8.0%)
Dec 2015
$38.65 M(+1219.2%)
$38.65 M(-8.2%)
Sep 2015
-
$42.10 M(-7.8%)
Jun 2015
-
$45.64 M(+2.9%)
Mar 2015
-
$44.35 M(+1413.7%)
Dec 2014
$2.93 M(-36.3%)
$2.93 M
Dec 2013
$4.60 M
-

FAQ

  • What is Spyre Therapeutics annual total assets?
  • What is the all time high annual total assets for Spyre Therapeutics?
  • What is Spyre Therapeutics annual total assets year-on-year change?
  • What is Spyre Therapeutics quarterly total assets?
  • What is the all time high quarterly total assets for Spyre Therapeutics?
  • What is Spyre Therapeutics quarterly total assets year-on-year change?

What is Spyre Therapeutics annual total assets?

The current annual total assets of SYRE is $341.86 M

What is the all time high annual total assets for Spyre Therapeutics?

Spyre Therapeutics all-time high annual total assets is $341.86 M

What is Spyre Therapeutics annual total assets year-on-year change?

Over the past year, SYRE annual total assets has changed by +$270.71 M (+380.52%)

What is Spyre Therapeutics quarterly total assets?

The current quarterly total assets of SYRE is $421.09 M

What is the all time high quarterly total assets for Spyre Therapeutics?

Spyre Therapeutics all-time high quarterly total assets is $487.60 M

What is Spyre Therapeutics quarterly total assets year-on-year change?

Over the past year, SYRE quarterly total assets has changed by $0.00 (0.00%)